FDA Drug Approval, A074450, MEXILETINE HYDROCHLORIDE
FDA Drug Approval, A074450, MEXILETINE HYDROCHLORIDE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
Contents: Summary Basis of Approval
ANDA: 074450
Company: ANI PHARMS
Drug Name: MEXILETINE HYDROCHLORIDE
Active Ingredients: MEXILETINE HYDROCHLORIDE
Strength: 250MG
Dosage Form/Route: CAPSULE;ORAL
Action Date: 05/16/1996
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AB
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details